GoodRx Collaborates With Sanofi To Offer Lantus Insulin At Fixed Rate 

GoodRx; and drugmaker Sanofi are collaborating to offer Sanofi’s Lantus (insulin glargine injection) 100 units/mL in the U.S. for only $35. The announcement comes after Sanofi’s recent move to lower its list price for Lantus and cap out-of-pocket costs at $35 for all consumers with commercial insurance, which goes into effect January 1, 2024.;;;

Consumers with a prescription for Lantus can use GoodRx at more than 70,000 U.S. retail pharmacies to access a 30-day supply of Lantus for only $35 regardless of insurance status.; To obtain . . .